Venture capital firms used to moan that business angels were unprofessional and hard to work with. But Europe's new breed of angel investor networks appears anything but that, says Mary Lisbeth D'Amico

Researchers at the Advanced Technology Institute at the University of Surrey recently reported that they have shown and observed a phenomenon called negative differential resistance - holding out the prospect of a new generation of cheap and fast semiconductors.

Venture capitalists are once again funding nanotech start-ups, but their overall investment is small compared with government funding and corporate R&D spending, says to a new report.

In his first interview since taking up the job, Bruno van Pottelsberghe, the 37-year-old newly appointed chief economist at the European Patent Office, bemoans the failure to create a single EU-wide patent.

"With engineering I view this year's failure as next year's opportunity to try it again...." Gordon E. Moore, co-founded Intel in 1968

Marc Van Montagu, Europe's founding father of genetically modified crops and a powerful advocate for their acceptance in Europe, speaks to Science|Business News Editor Thomas Lau.

Scientific Generics, the technology consultancy based in Cambridge, UK, has exported its 'Innovation Angels' methodology to Oslo in a pilot programme supported by the industrial development agency Innovation Norway.

Micromet AG, a spin-off from the Institute for Immunology at Munich University, said it has agreed to grant four licenses of its single chain antibody technology to Abbott Laboratories, Alligator Bioscience AB, Haptogen Ltd. and an unnamed biopharmaceutical company, for the development of cancer treatments.